MX2022006278A - Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos. - Google Patents

Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos.

Info

Publication number
MX2022006278A
MX2022006278A MX2022006278A MX2022006278A MX2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A MX 2022006278 A MX2022006278 A MX 2022006278A
Authority
MX
Mexico
Prior art keywords
diagnosis
prevention
treatment
malignant tumours
salmon proteins
Prior art date
Application number
MX2022006278A
Other languages
English (en)
Inventor
Cusani Alberto Bartorelli
Original Assignee
Cusani Alberto Bartorelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cusani Alberto Bartorelli filed Critical Cusani Alberto Bartorelli
Publication of MX2022006278A publication Critical patent/MX2022006278A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Se describen proteínas de salmón UK 114 para uso en el tratamiento, diagnóstico y prevención de tumores malignos.
MX2022006278A 2019-11-26 2020-11-23 Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos. MX2022006278A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000022203A IT201900022203A1 (it) 2019-11-26 2019-11-26 Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
PCT/EP2020/083069 WO2021105059A1 (en) 2019-11-26 2020-11-23 Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours

Publications (1)

Publication Number Publication Date
MX2022006278A true MX2022006278A (es) 2022-08-15

Family

ID=70009105

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006278A MX2022006278A (es) 2019-11-26 2020-11-23 Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos.

Country Status (8)

Country Link
US (1) US20230000946A1 (es)
EP (1) EP4065154A1 (es)
JP (1) JP2023504241A (es)
CN (1) CN114761034A (es)
CA (1) CA3159292A1 (es)
IT (1) IT201900022203A1 (es)
MX (1) MX2022006278A (es)
WO (1) WO2021105059A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270618B (it) 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
US20010014471A1 (en) 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Also Published As

Publication number Publication date
US20230000946A1 (en) 2023-01-05
JP2023504241A (ja) 2023-02-02
EP4065154A1 (en) 2022-10-05
IT201900022203A1 (it) 2021-05-26
WO2021105059A1 (en) 2021-06-03
CN114761034A (zh) 2022-07-15
CA3159292A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
PH12020551923A1 (en) Methods and compositions for treating cancer
GEP20237458B (en) Combination product of bcl-2 inhibitor and mdm2 inhibitor and use thereof in the prevention and/or treatment of diseases
PH12021550152A1 (en) Anti-cd112r compositions and methods
MX2019011148A (es) Metodos de tratamiento.
SG10201809411PA (en) Methods of treating early breast cancer with trastuzumab-mcc-dm1 and pertuzumab
MX2022007994A (es) Derivados de arilciclohexilamina y su uso en el tratamiento de trastornos psiquiátricos.
PH12019502197A1 (en) Macrocyclic compound and uses thereof
AU2016304856A8 (en) Mechanism of resistance to BET bromodomain inhibitors
PH12021551036A1 (en) Anti-liv1 immune cell cancer therapy
MX2020009733A (es) Composiciones.
MX2021011723A (es) Ligandos de pseudocinasa tyk2.
MX2021009555A (es) Ligandos de pseudocinasa tyk2.
MX2018015172A (es) Metodos para tratar cancer pancreatico.
PH12021551047A1 (en) Anti-ptk7 immune cell cancer therapy
MX2022005563A (es) Ligandos de la pseudoquinasa tyk2.
MX2018009499A (es) Anticuerpos monoclonales especificos de egfl6 y metodos de su uso.
PH12021550122A1 (en) Solubilized apyrases, methods and use
MX2021003262A (es) Metodos de tratamiento.
MX2020013103A (es) Metodos de uso de cd24 para la prevencion y tratamiento de recaida de leucemia.
PH12021550121A1 (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
MX2020000636A (es) Proteinas sinteticas y usos terapeuticos de las mismas.
MX2022000263A (es) Nuevos antigenos y metodos contra el cancer.
MX2021015765A (es) Nuevos antigenos y metodos contra el cancer.
MX2021004453A (es) Nuevos antigenos y metodos contra el cancer.